Tag: entrepreneurs
-
Start-Up Licensing Antibody Eye Drops for Dry Eye Disease
An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease.
-
Streamline Your Salon Business for Growth and Efficiency
This can include anything from improving communication between employees to automating certain tasks.
-
Technology Showcased to Ease Mental Health Interventions
A group of industry and academic researchers at a scientific meeting displayed advances in technology to improve access to therapy for people with mental disorders.
-
Psychoactive Drug Start-Up Raises $40M in Early Funds
A new company is underway developing drugs to treat PTSD and other disorders with psychoactive compounds claimed to be safer than current psychedelics.
-
Human Ovary Organoid Model Demonstrated, Licensed
A university lab created and licensed to a biotechnology company a model human ovary made of functioning cells for female reproductive health applications.
-
Biotech to Synthesize Proteins in Microgravity
A biotechnology company synthesizing pure proteins from DNA is preparing to test its process in weightless conditions on the International Space Station.
-
Bio-Electric Regeneration Company Adds $8M in Seed Funds
A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds.
-
Biotech Drug Shown to Kill Prostate Tumor Cells
Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue.
-
Green Energy Chemical Company Starts-Up, Raises $15M
A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis.
-
Allergy Antibody Biotech Gains $40M in New Funds
A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round.